Successful Treatment of Multiple Alopecia Areata With Contact Immunotherapy: Supportive Usage of Oral Antihistamine and Topical Corticosteroid

Authors

  • Maya Kaga-Kamijo Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
  • Shigaku Ikeda Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan

DOI:

https://doi.org/10.17140/DRMTOJ-2-123

Keywords:

Alopecia areata, Atopic dermatitis, Contact immunotherapy

Abstract

Contact immunotherapy using diphenylcyclopropenone (DPCP) is a commonly used first-line
therapeutic technique for patients with alopecia areata (AA). We present here a successful immunotherapy
for AA female case with atopic diathesis, using oral antihistamine and topical
corticosteroid supportively on DPCP. Courses of clinical and laboratory findings suggested that
indirect effect to allergic inflammation by antihistamine drugs contributed to AA regression in
our case.

References

Gilhar A, Etzioni A, Paus R. Alopecia areata. N Engl J Med. 2012; 366(16): 1515-1525. doi: 10.1056/NEJMra1103442

Barahmani N, Schabath MB, Duvic M. History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Der-matol. 2009; 61: 581-591. doi: 10.1016/j.jaad.2009.04.031

Chu SY, Chen YJ, Tseng WC, et al. Comorbidity profiles among patients with alopecia areata: The importance of onset age, a nationwide population-based study. J Am Acad Dermatol. 2011; 65: 949-956. doi: 10.1016/j.jaad.2010.08.032

Harries MJ, Sun J, Paus R, King LE Jr. Management of alo-pecia areata. BMJ. 2010; 341: c3671. doi: 10.1136/bmj.c3671

Alkhalifah A, Alsantali A, Wang E, et al. Alopecia areataup-date: Part II. Treatment. J Am Acad Dermatol. 2010; 62: 191- 202. doi: 10.1016/j.jaad.2009.10.031

Garg S, Messenger AG. Alopecia areata: Evidence based treat-ments. Semin Cutan Med Surg. 2009; 28: 15-18. doi: 10.1016/j. sder.2008.12.002

Yoshimasu T, Furukawa F. Modified immunotherapy for alo-pecia areata. Autoimmun Rev. 2016; 15: 664-667. doi: 10.1016/j. autrev.2016.02.021

Lamb RC, Young D, Holmes S. Retrospective review of di-phencyprone in the treatment of alopecia areata. Clini Exp Der-matol. 2016; 41(4): 352-358. doi: 10.1111/ced.12776

Ogawa H, Ueki R, Nishiyama S, et al. The effect of an anti-allergic drug on the disease activity of alopecia areata. Skin Res. 1994; 36: 60-68. doi: 10.11340/skinresearch1959.36.60

Inui S, Takeshi N, Naoyuki T, Itami S. Fexofenadine hy-drochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases. J Dermatol. 2009; 36: 323-327. doi: 10.1111/j.1346- 8138.2009.00647.x

Ohyama M, Shimizu A, Tanaka K, Amagai M. Experimental evaluation of ebastine, a second-generation antihistamine, as a supportive medication for alopecia areata. J Dermatol. 2010; 58: 154-157. doi: 10.1016/j.jdermsci.2010.03.009

Downloads

Published

2017-05-09

How to Cite

Maya Kaga-Kamijo, & Shigaku Ikeda. (2017). Successful Treatment of Multiple Alopecia Areata With Contact Immunotherapy: Supportive Usage of Oral Antihistamine and Topical Corticosteroid. Dermatology, 2(2), 18–20. https://doi.org/10.17140/DRMTOJ-2-123

Issue

Vol. 2 No. 2 (2017): Volume 2 Issue 2 2017

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Dermatology (DER) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.

Most read articles by the same author(s)